Evidence map›Paper›PMID 31134289›Full record

ReviewRheumatology international2019

Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.

Mohamed Bedaiwi, Ibrahim A Al-Homood, Ayman El-Garf, Imad Uthman, Nancy Sunna, Reenad Nassier, Haytham Mohamed, Jamal Al Saleh

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Mohamed BedaiwiDivision of Rheumatology, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia. dr.mkbedaiwi@gmail.com.
Ibrahim A Al-HomoodDepartment of Medical Specialties, Rheumatology Section, King Fahad Medical City, Riyadh, Saudi Arabia.
Ayman El-GarfRheumatology Department, Cairo University Hospitals, Cairo University, Cairo, Egypt.ORCID http://orcid.org/0000-0001-6343-9190
Imad UthmanDivision of Rheumatology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID http://orcid.org/0000-0001-8285-6483
Nancy SunnaPfizer Inc, Amman, Jordan.ORCID http://orcid.org/0000-0003-2088-1434
Reenad NassierPfizer Inc, Jeddah, Saudi Arabia.
Haytham MohamedPfizer Inc, Jeddah, Saudi Arabia.ORCID http://orcid.org/0000-0002-2883-3317
Jamal Al SalehRheumatology Unit, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
American University of Beirut Medical Center · LBCairo University hospitals · EGDubai Health Authority · AEKing Fahd Medical City · SAKing Saud Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriatic arthritis (PsA) is a chronic, inflammatory arthropathy occurring in up to 30% of patients with psoriasis, and is characterized by multiple manifestations including peripheral arthritis, enthesitis, dactylitis, spondylitis, and psoriatic skin and nail disease. This complex and heterogeneous disease is poorly understood and its diagnosis and treatment are suboptimal, particularly in Africa and the Middle East, where very few studies into the impact of PsA have been carried out. This article aims to highlight the disease burden of PsA in the region as well as to identify unmet clinical needs. A non-systematic review was carried out in the PubMed database and the most relevant publications were selected. Expert rheumatologists practicing in Africa and the Middle East provide an insight into the challenges of treating PsA in daily practice, along with recommendations for improvements.

Indexed as

AfricaAnti-Inflammatory AgentsArthritis, PsoriaticHealth Services Needs and DemandHumansIncidenceMiddle EastNeeds AssessmentPrevalenceAnti-Inflammatory AgentsAfricaDisease burdenMiddle EastPrevalencePsoriatic arthritisSpondyloarthritis

Identifiers

PMID31134289
OpenAlexW2947596000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.